FiercePharma

Critical Milestone for Patients With Uncontrolled Cholesterol who Require Additional Intensive LDL-C Reduction

To view the multimedia assets associated with this press release, please click: http://www.multivu.com/players/English/7414052-amgen-repatha/. The EC approved Repatha ...
California Healthline

Cholesterol Drug Prevents Heart Attacks — But It Doesn’t Come Cheap

Stories that are breaking new ground in the health care system. Have a story suggestion? Let us know. WASHINGTON — For the first time, research shows that a pricey new medication called Repatha not ...
TCTMD

European Commission Approves Amgen's New Cholesterol-Lowering Medication Repatha™ (evolocumab), The First PCSK9 Inhibitor To Be Approved In The World, For Treatment Of High ...

The treatment of adults with primary hypercholesterolemia (heterozygous familial and non-familial [HeFH]) or mixed dyslipidemia, as an adjunct to diet: in combination with a statin or statin with ...
Finanznachrichten

European Commission Approves Amgen's New Cholesterol-Lowering Medication Repatha' (evolocumab), The First PCSK9 Inhibitor To Be Approved In The World, For Treatment Of High ...

"We are proud that our cholesterol-lowering medication, Repatha, is the first PCSK9 inhibitor to be approved by any regulatory agency in the world," said Sean E. Harper, M.D., executive vice president ...